Found 46 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors EARLY_PHASE1 This trial studies how well an investigational scan called 68Ga-DOTATATE PE...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial
Simplification of Low Level Internal Dosimetry N/A This is a pilot study with the primary aim being to identify the minimum nu...
Show More Location
The Royal Marsden NHS Foundation Trust
Learn More & Join Trial
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors PHASE2 Background:
People with von Hippel-Lindau (VHL) can have problems with a v...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) PHASE1 Background:
A neuroendocrine tumor is a rare type of tumor. It comes from ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome PHASE2 Between 10% and 15% of patients with endogenous hypercortisolism (Cushing s...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Clinical Application of the J-PET Scanner Prototype N/A Positron emission tomography (PET), an advanced diagnostic imaging techniqu...
Show More Location
Department of Endocrinology and Nuclear Medicine, University Hospital in Krakow
Learn More & Join Trial
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract N/A The purpose of the study is to understand the extent and degree of somatost...
Show More Location
H Lee Moffitt Cancer & Research Institute
Learn More & Join Trial
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer PHASE3 DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTA...
Show More Location
CHU Grenoble Alpes
Learn More & Join Trial
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma PHASE1 This phase I/II tests the safety, side effects, best dose and how well givi...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial